Apellis Pharmaceuticals, Inc. has 904 employees, according to Revelio Labs workforce intelligence data. The YoY growth rate is 3.3%.
Data source: Revelio Labs Coverage: Global workforce Latest update: September 2025
At Apellis, we are committed to developing transformative therapies for people living with a broad range of debilitating diseases by controlling complement, part of the body’s immune system. Our work is rooted centrally at C3, which is the only target in the complement cascade that addresses all three pathways that can drive disease. Targeting C3 has broad platform potential to treat many diseases where patients have few or no treatment options available. Our programs across ophthalmology, nephrology, hematology, and neurology are further exploring what is possible by targeting C3. You can view our community guidelines here: Community guidelines: http://bit.ly/476Q8
As of September 2025
Apellis Pharmaceuticals
workforce metrics
Headcount
904
Avg. Salary
$195.5k
Tenure
2.4yr
Growth Rate
3.3%
Hiring Rate
Attrition Rate
For even more metrics data,
reach out to our sales team.
Interactive chart of Apellis Pharmaceuticals annual worldwide employee count from 2023 to 2025.
Would you like to see the latest employee headcount data?
Would you like to see the latest employee geographic data?
Interactive chart of Apellis Pharmaceuticals annual active job postings from 2023 to 2025.
Would you like to see the latest active job postings data?
Sentiment Topics
Would you like to see the latest employee sentiment data?